Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts

Journal of Hepatology

Volumn 62, Issue 1, 2015, Pages 198-207

  Raggi, Chiara ^a   Invernizzi, Pietro ^a   Andersen, Jesper B ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Cancer stem cells; Cholangiocarcinoma; Tumour associated macrophages; Tumour microenvironment

Indexed keywords

BETA CATENIN; INTERLEUKIN 6; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAF PROTEIN; RAS PROTEIN; SONIC HEDGEHOG PROTEIN; STAT PROTEIN; TRANSFORMING GROWTH FACTOR BETA; WNT PROTEIN;

BILE DUCT CARCINOMA; CANCER GROWTH; CANCER STEM CELL; CANCER THERAPY; CELL TRANSFORMATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE ASSOCIATION; EMBRYO DEVELOPMENT; GENE TARGETING; HEDGEHOG; HEPATIC PROGENITOR CELL; HUMAN; INFLAMMATION; LIVER CELL; MALIGNANT TRANSFORMATION; META ANALYSIS (TOPIC); MOLECULAR BIOLOGY; MOLECULARLY TARGETED THERAPY; NONHUMAN; ONCOGENE N RAS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM LIKE PLASTICITY; TUMOR MICROENVIRONMENT; BILE DUCT TUMOR; DISEASE COURSE; INTRAHEPATIC BILE DUCT; PATHOLOGY;

BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; HUMANS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84918543521     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.09.007     Document Type: Review

References (123)

1. M. Kumar, X. Zhao, and X.W. Wang Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci 1 2011 5
2. B. Blechacz, M. Komuta, T. Roskams, and G.J. Gores Clinical diagnosis and staging of cholangiocarcinoma Nat Rev Gastroenterol Hepatol 8 2011 512 522
3. J. Bridgewater, P.R. Galle, S.A. Khan, J.M. Llovet, J.W. Park, and T. Patel Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 2014 1268 1289
4. S. Rizvi, and G.J. Gores Pathogenesis, diagnosis, and management of cholangiocarcinoma Gastroenterology 145 2013 1215 1229
5. V. Cardinale, G. Carpino, L. Reid, E. Gaudio, and D. Alvaro Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity World J Gastrointest Oncol 4 2012 94 102
6. V. Cardinale, G. Carpino, L.M. Reid, E. Gaudio, and D. Alvaro Cholangiocarcinoma: a cancer in search of the right classification Hepatology 56 2012 1585 1586
7. V. Cardinale, Y. Wang, G. Carpino, L.M. Reid, E. Gaudio, and D. Alvaro Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands Hepatology 55 2012 2041 2042
8. J.B. Andersen, and S.S. Thorgeirsson Genetic profiling of intrahepatic cholangiocarcinoma Curr Opin Gastroenterol 28 2012 266 272
9. D. Sia, V. Tovar, A. Moeini, and J.M. Llovet Intrahepatic cholangiocarcinoma: pathogenesis and rationale for molecular therapies Oncogene 32 2013 4861 4870
10. J.B. Andersen, B. Spee, B.R. Blechacz, I. Avital, M. Komuta, and A. Barbour Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors Gastroenterology 142 2012 e1015
11. D. Sia, Y. Hoshida, A. Villanueva, S. Roayaie, J. Ferrer, and B. Tabak Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes Gastroenterology 144 2013 829 840
12. R.A. Allen, and J.R. Lisa Combined liver cell and bile duct carcinoma Am J Pathol 25 1949 647 655
13. M. Komuta, B. Spee, S. Vander Borght, R. De Vos, C. Verslype, and R. Aerts Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin Hepatology 47 2008 1544 1556
14. J.S. Lee, J. Heo, L. Libbrecht, I.S. Chu, P. Kaposi-Novak, and D.F. Calvisi A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410 416
15. J.S. Lee, and S.S. Thorgeirsson Comparative and integrative functional genomics of HCC Oncogene 25 2006 3801 3809
16. E.P. Berthiaume, and J. Wands The molecular pathogenesis of cholangiocarcinoma Semin Liver Dis 24 2004 127 137
17. H. Zhou, H. Wang, D. Zhou, Q. Wang, S. Zou, and Q. Tu Hepatitis B virus-Associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis Eur J Cancer 46 2010 1056 1061
18. K. Nomoto, K. Tsuneyama, C. Cheng, H. Takahashi, R. Hori, and Y. Murai Intrahepatic cholangiocarcinoma arising in cirrhotic liver frequently expressed p63-positive basal/stem-cell phenotype Pathol Res Pract 202 2006 71 76
19. T. Roskams Different types of liver progenitor cells and their niches J Hepatol 45 2006 1 4
20. T. Roskams Liver stem cells and their implication in hepatocellular and cholangiocarcinoma Oncogene 25 2006 3818 3822
21. M. Kitade, V.M. Factor, J.B. Andersen, A. Tomokuni, K. Kaji, and H. Akita Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signalling Genes Dev 27 2013 1706 1717
22. H. Kim, C. Park, K.H. Han, J. Choi, Y.B. Kim, and J.K. Kim Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype J Hepatol 40 2004 298 304
23. H.G. Woo, J.H. Lee, J.H. Yoon, C.Y. Kim, H.S. Lee, and J.J. Jang Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma Cancer Res 70 2010 3034 3041
24. H.G. Woo, E.S. Park, J.H. Cheon, J.H. Kim, J.S. Lee, and B.J. Park Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma Clin Cancer Res 14 2008 2056 2064
25. J.Y. Seok, D.C. Na, H.G. Woo, M. Roncalli, S.M. Kwon, and J.E. Yoo A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition Hepatology 55 2012 1776 1786
26. D. Cazals-Hatem, S. Rebouissou, P. Bioulac-Sage, O. Bluteau, H. Blanche, and D. Franco Clinical and molecular analysis of combined hepatocellular-cholangiocarcinomas J Hepatol 41 2004 292 298
27. H. Fujii, X.G. Zhu, T. Matsumoto, M. Inagaki, Y. Tokusashi, and N. Miyokawa Genetic classification of combined hepatocellular-cholangiocarcinoma Hum Pathol 31 2000 1011 1017
28. M. Murata, Y. Miyoshi, K. Iwao, H. Wada, K. Shibata, and H. Tateishi Combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features: genetic analysis for histogenesis Hepatol Res 21 2001 220 227
29. G. Carpino, V. Cardinale, P. Onori, A. Franchitto, P.B. Berloco, and M. Rossi Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages J Anat 220 2012 186 199
30. N. Razumilava, and G.J. Gores Notch-driven carcinogenesis: the merging of hepatocellular cancer and cholangiocarcinoma into a common molecular liver cancer subtype J Hepatol 58 2013 1244 1245
31. J. Zucman-Rossi, J.C. Nault, and L. Zender Primary liver carcinomas can originate from different cell types: a new level of complexity in hepatocarcinogenesis Gastroenterology 145 2013 53 55
32. B. Fan, Y. Malato, D.F. Calvisi, S. Naqvi, N. Razumilava, and S. Ribback Cholangiocarcinomas can originate from hepatocytes in mice J Clin Invest 122 2012 2911 2915
33. A. Holczbauer, V.M. Factor, J.B. Andersen, J.U. Marquardt, D.E. Kleiner, and C. Raggi Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types Gastroenterology 145 2013 221 231
34. S. Sekiya, and A. Suzuki Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes J Clin Invest 122 2012 3914 3918
35. R.V. Guest, L. Boulter, T.J. Kendall, S.E. Minnis-Lyons, R. Walker, and S.J. Wigmore Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma Cancer Res 74 2014 1005 1010
36. D.R. Pattabiraman, and R.A. Weinberg Tackling the cancer stem cells - what challenges do they pose? Nat Rev Drug Discov 13 2014 497 512
37. J.U. Marquardt, C. Raggi, J.B. Andersen, D. Seo, I. Avital, and D. Geller Human hepatic cancer stem cells are characterized by common stemness traits and diverse oncogenic pathways Hepatology 54 2011 1031 1042
38. S. Ma, K.W. Chan, L. Hu, T.K. Lee, J.Y. Wo, and I.O. Ng Identification and characterization of tumourigenic liver cancer stem/progenitor cells Gastroenterology 132 2007 2542 2556
39. C. Raggi, V.M. Factor, D. Seo, A. Holczbauer, M.C. Gillen, and J.U. Marquardt Epigenetic reprogramming modulates malignant properties of human liver cancer Hepatology 59 2014 2251 2262
40. T. Yamashita, M. Forgues, W. Wang, J.W. Kim, Q. Ye, and H. Jia EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma Cancer Res 68 2008 1451 1461
41. T. Kokuryo, Y. Yokoyama, and M. Nagino Recent advances in cancer stem cell research for cholangiocarcinoma J Hepatobiliary Pancreat Sci 19 2012 606 613
42. L. Fan, F. He, H. Liu, J. Zhu, Y. Liu, and Z. Yin CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma BMC Cancer 11 2011 320
43. S. Agrawal, B.W. Kuvshinoff, T. Khoury, J. Yu, M.M. Javle, and C. LeVea CD24 expression is an independent prognostic marker in cholangiocarcinoma J Gastrointest Surg 11 2007 445 451
44. L. Sulpice, M. Rayar, B. Turlin, E. Boucher, P. Bellaud, and M. Desille Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma J Surg Res 192 2014 117 123
45. M. Wang, J. Xiao, J. Jiang, and R. Qin CD133 and ALDH may be the molecular markers of cholangiocarcinoma stem cells Int J Cancer 128 2011 1996 1997
46. F. Zhang, X.P. Chen, W. Zhang, H.H. Dong, S. Xiang, and W.G. Zhang Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence Histopathology 52 2008 224 232
47. A. Villanueva, and J.M. Llovet Second-line therapies in hepatocellular carcinoma: emergence of resistance to sorafenib Clin Cancer Res 18 2012 1824 1826
48. C.M. Morell, and M. Strazzabosco Notch signalling and new therapeutic options in liver disease J Hepatol 60 2014 885 890
49. Y. Zong, and B.Z. Stanger Molecular mechanisms of liver and bile duct development Wiley Interdiscip Rev Dev Biol 1 2012 643 655
50. J. Gao, Z. Song, Y. Chen, L. Xia, J. Wang, and R. Fan Deregulated expression of Notch receptors in human hepatocellular carcinoma Dig Liver Dis 40 2008 114 121
51. S. Zender, I. Nickeleit, T. Wuestefeld, I. Sorensen, D. Dauch, and P. Bozko A critical role for notch signalling in the formation of cholangiocellular carcinomas Cancer Cell 23 2013 784 795
52. A.E. Sirica, and G.J. Gores Desmoplastic stroma and cholangiocarcinoma: clinical implications and therapeutic targeting Hepatology 59 2014 2397 2402
53. S. Mikhail, and A.R. He Liver cancer stem cells Int J Hepatol 2011 2011 486954
54. C.K. Lau, Z.F. Yang, and S.T. Fan Role of stem cells in normal liver and cancer Anticancer Agents Med Chem 11 2011 522 528
55. A. Omenetti, Y. Popov, Y. Jung, S.S. Choi, R.P. Witek, and L. Yang The hedgehog pathway regulates remodelling responses to biliary obstruction in rats Gut 57 2008 1275 1282
56. L. Panman, A. Galli, N. Lagarde, O. Michos, G. Soete, and A. Zuniga Differential regulation of gene expression in the digit forming area of the mouse limb bud by SHH and gremlin 1/FGF-mediated epithelial-mesenchymal signalling Development 133 2006 3419 3428
57. G. Xie, G. Karaca, M. Swiderska-Syn, G.A. Michelotti, L. Kruger, and Y. Chen Cross-talk between notch and hedgehog regulates hepatic stellate cell fate Hepatology 58 2013 1801 1813
58. M. Kango-Singh, and A. Singh Regulation of organ size: insights from the Drosophila Hippo signalling pathway Dev Dyn 238 2009 1627 1637
59. J. Huang, S. Wu, J. Barrera, K. Matthews, and D. Pan The Hippo signalling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP Cell 122 2005 421 434
60. I. Lian, J. Kim, H. Okazawa, J. Zhao, B. Zhao, and J. Yu The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation Genes Dev 24 2010 1106 1118
61. L. Lu, Y. Li, S.M. Kim, W. Bossuyt, P. Liu, and Q. Qiu Hippo signalling is a potent in vivo growth and tumour suppressor pathway in the mammalian liver Proc Natl Acad Sci U S A 107 2010 1437 1442
62. G.J. Kim, H. Kim, and Y.N. Park Increased expression of Yes-Associated protein 1 in hepatocellular carcinoma with stemness and combined hepatocellular-cholangiocarcinoma PLoS One 8 2013 e75449
63. K.P. Lee, J.H. Lee, T.S. Kim, T.H. Kim, H.D. Park, and J.S. Byun The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumourigenesis Proc Natl Acad Sci U S A 107 2010 8248 8253
64. T.G. Bird, S. Lorenzini, and S.J. Forbes Activation of stem cells in hepatic diseases Cell Tissue Res 331 2008 283 300
65. F. Tacke, T. Luedde, and C. Trautwein Inflammatory pathways in liver homeostasis and liver injury Clin Rev Allergy Immunol 36 2009 4 12
66. A.W. Duncan, C. Dorrell, and M. Grompe Stem cells and liver regeneration Gastroenterology 137 2009 466 481
67. N.D. Theise, J.L. Yao, K. Harada, P. Hytiroglou, B. Portmann, and S.N. Thung Hepatic 'stem cell' malignancies in adults: four cases Histopathology 43 2003 263 271
68. X.Z. Wu, and D. Chen Origin of hepatocellular carcinoma: role of stem cells J Gastroenterol Hepatol 21 2006 1093 1098
69. S. Sell, and H.A. Dunsford Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma Am J Pathol 134 1989 1347 1363
70. J. Li, N. Razumilava, G.J. Gores, S. Walters, T. Mizuochi, and R. Mourya Biliary repair and carcinogenesis are mediated by IL-33-dependent cholangiocyte proliferation J Clin Invest 124 2014 3241 3251
71. J.B. Andersen, and S.S. Thorgeirsson A perspective on molecular therapy in cholangiocarcinoma: present status and future directions Hepat Oncol 1 2014 143 157
72. J. Massague, and Q. Xi TGF-beta control of stem cell differentiation genes FEBS Lett 586 2012 1953 1958
73. F. Itoh, T. Watabe, and K. Miyazono Roles of TGF-beta family signals in the fate determination of pluripotent stem cells Semin Cell Dev Biol 32C 2014 98 106
74. Y. Sato, K. Harada, K. Itatsu, H. Ikeda, Y. Kakuda, and S. Shimomura Epithelial-mesenchymal transition induced by transforming growth factor-{beta}1/Snail activation aggravates invasive growth of cholangiocarcinoma Am J Pathol 177 2010 141 152
75. H. Isomoto, S. Kobayashi, N.W. Werneburg, S.F. Bronk, M.E. Guicciardi, and D.A. Frank Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells Hepatology 42 2005 1329 1338
76. T. Zheng, X. Hong, J. Wang, T. Pei, Y. Liang, and D. Yin Gankyrin promotes tumour growth and metastasis through activation of IL-6/STAT3 signalling in human cholangiocarcinoma Hepatology 59 2014 935 946
77. T. Bekaii-Saab, M.A. Phelps, X. Li, M. Saji, L. Goff, and J.S. Kauh Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers J Clin Oncol 29 2011 2357 2363
78. G.Y. Gwak, J.H. Yoon, C.M. Shin, Y.J. Ahn, J.K. Chung, and Y.A. Kim Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas J Cancer Res Clin Oncol 131 2005 649 652
79. M. Trauner, P. Fickert, and R.E. Stauber Inflammation-induced cholestasis J Gastroenterol Hepatol 14 1999 946 959
80. W.W. Lin, and M. Karin A cytokine-mediated link between innate immunity, inflammation, and cancer J Clin Invest 117 2007 1175 1183
81. J.E. Eaton, J.A. Talwalkar, K.N. Lazaridis, G.J. Gores, and K.D. Lindor Pathogenesis of primary sclerosing cholangitis and advances in diagnosis and management Gastroenterology 145 2013 521 536
82. G. He, and M. Karin NF-kappaB and STAT3 - key players in liver inflammation and cancer Cell Res 21 2011 159 168
83. A. Sica, P. Invernizzi, and A. Mantovani Macrophage plasticity and polarization in liver homeostasis and pathology Hepatology 59 2014 2034 2042
84. M. Anson, A.M. Crain-Denoyelle, V. Baud, F. Chereau, A. Gougelet, and B. Terris Oncogenic beta-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice J Clin Invest 122 2012 586 599
85. M. Massani, T. Stecca, L. Fabris, E. Caratozzolo, C. Ruffolo, and A. Furlanetto Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: a novel in vitro model to study tumour-stroma interactions Oncol Rep 30 2013 1143 1148
86. A. Techasen, W. Loilome, N. Namwat, H. Dokduang, J. Jongthawin, and P. Yongvanit Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells Asian Pac J Cancer Prev 13 2012 115 118
87. L. Fabris, M. Cadamuro, L. Moserle, J. Dziura, X. Cong, and L. Sambado Nuclear expression of S100A4 calcium-binding protein increases cholangiocarcinoma invasiveness and metastasization Hepatology 54 2011 890 899
88. K.P. Olive, M.A. Jacobetz, C.J. Davidson, A. Gopinathan, D. McIntyre, and D. Honess Inhibition of Hedgehog signalling enhances delivery of chemotherapy in a mouse model of pancreatic cancer Science 324 2009 1457 1461
89. C. Chuaysri, P. Thuwajit, A. Paupairoj, S. Chau-In, T. Suthiphongchai, and C. Thuwajit Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma Oncol Rep 21 2009 957 969
90. S.S. Choi, A. Omenetti, R.P. Witek, C.A. Moylan, W.K. Syn, and Y. Jung Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis Am J Physiol Gastrointest Liver Physiol 297 2009 G1093 G1106
91. C.D. Fingas, J.C. Mertens, N. Razumilava, S. Sydor, S.F. Bronk, and J.D. Christensen Polo-like kinase 2 is a mediator of hedgehog survival signalling in cholangiocarcinoma Hepatology 58 2013 1362 1374
92. C.D. Fingas, S.F. Bronk, N.W. Werneburg, J.L. Mott, M.E. Guicciardi, and S.C. Cazanave Myofibroblast-derived PDGF-BB promotes Hedgehog survival signalling in cholangiocarcinoma cells Hepatology 54 2011 2076 2088
93. C.D. Fingas, J.C. Mertens, N. Razumilava, S.F. Bronk, A.E. Sirica, and G.J. Gores Targeting PDGFR-beta in cholangiocarcinoma Liver Int 32 2012 400 409
94. M. Cadamuro, G. Nardo, S. Indraccolo, L. Dall'olmo, L. Sambado, and L. Moserle Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-Associated fibroblasts in cholangiocarcinoma Hepatology 58 2013 1042 1053
95. J.C. Mertens, C.D. Fingas, J.D. Christensen, R.L. Smoot, S.F. Bronk, and N.W. Werneburg Therapeutic effects of deleting cancer-Associated fibroblasts in cholangiocarcinoma Cancer Res 73 2013 897 907
96. S. Rizvi, J.C. Mertens, S.F. Bronk, P. Hirsova, H. Dai, and L.R. Roberts Platelet-derived growth factor primes cancer-Associated fibroblasts for apoptosis J Biol Chem 289 2014 22835 22849
97. B. Ruffell, N.I. Affara, and L.M. Coussens Differential macrophage programming in the tumour microenvironment Trends Immunol 33 2012 119 126
98. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumour-Associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
99. G. Solinas, S. Schiarea, M. Liguori, M. Fabbri, S. Pesce, and L. Zammataro Tumour-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumour cell motility J Immunol 185 2010 642 652
100. A. Mantovani, and A. Sica Macrophages, innate immunity and cancer: balance, tolerance, and diversity Curr Opin Immunol 22 2010 231 237
101. A. Mantovani, G. Germano, F. Marchesi, M. Locatelli, and S.K. Biswas Cancer-promoting tumour-Associated macrophages: new vistas and open questions Eur J Immunol 41 2011 2522 2525
102. H. Hasita, Y. Komohara, H. Okabe, T. Masuda, K. Ohnishi, and X.F. Lei Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma Cancer Sci 101 2010 1913 1919
103. S. Ohira, K. Itatsu, M. Sasaki, K. Harada, Y. Sato, and Y. Zen Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma Pathol Int 56 2006 381 389
104. S. Ohira, M. Sasaki, K. Harada, Y. Sato, Y. Zen, and K. Isse Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumour necrosis factor-Alpha and stromal-derived factor-1 released in stroma Am J Pathol 168 2006 1155 1168
105. A. Techasen, N. Namwat, W. Loilome, P. Bungkanjana, N. Khuntikeo, and A. Puapairoj Tumour necrosis factor-Alpha (TNF-Alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma Med Oncol 29 2012 3083 3091
106. D. Leyva-Illades, M. McMillin, M. Quinn, and S. Demorrow Cholangiocarcinoma pathogenesis: role of the tumour microenvironment Transl Gastrointest Cancer 1 2012 71 80
107. P.Y. Zhuang, J. Shen, X.D. Zhu, L. Lu, L. Wang, and Z.Y. Tang Prognostic roles of cross-talk between peritumoural hepatocytes and stromal cells in hepatocellular carcinoma involving peritumoural VEGF-C, VEGFR-1, and VEGFR-3 PLoS One 8 2013 e64598
108. A. Franchitto, P. Onori, A. Renzi, G. Carpino, R. Mancinelli, and D. Alvaro Expression of vascular endothelial growth factors and their receptors by hepatic progenitor cells in human liver diseases Hepatobiliary Surg Nutr 2 2013 68 77
109. T. Borovski, E.M.F. De Sousa, L. Vermeulen, and J.P. Medema Cancer stem cell niche: the place to be Cancer Res 71 2011 634 639
110. H. Korkaya, S. Liu, and M.S. Wicha Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots Clin Cancer Res 17 2011 6125 6129
111. P. Lu, V.M. Weaver, and Z. Werb The extracellular matrix: a dynamic niche in cancer progression J Cell Biol 196 2012 395 406
112. J. Schrader, T.T. Gordon-Walker, R.L. Aucott, M. van Deemter, A. Quaas, and S. Walsh Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells Hepatology 53 2011 1192 1205
113. J.B. Andersen, V.M. Factor, J.U. Marquardt, C. Raggi, Y.H. Lee, and D. Seo An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer Sci Transl Med 2 2010 54ra77
114. M. Jinushi, S. Chiba, H. Yoshiyama, K. Masutomi, I. Kinoshita, and H. Dosaka-Akita Tumour-Associated macrophages regulate tumourigenicity and anticancer drug responses of cancer stem/initiating cells Proc Natl Acad Sci U S A 108 2011 12425 12430
115. J.B. Mitchem, D.J. Brennan, B.L. Knolhoff, B.A. Belt, Y. Zhu, and D.E. Sanford Targeting tumour-infiltrating macrophages decreases tumour-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses Cancer Res 73 2013 1128 1141
116. L. Boulter, O. Govaere, T.G. Bird, S. Radulescu, P. Ramachandran, and A. Pellicoro Macrophage-derived Wnt opposes Notch signalling to specify hepatic progenitor cell fate in chronic liver disease Nat Med 18 2012 572 579
117. K. Sugimachi, K. Taguchi, S. Aishima, S. Tanaka, M. Shimada, and K. Kajiyama Altered expression of beta-catenin without genetic mutation in intrahepatic cholangiocarcinoma Mod Pathol 14 2001 900 905
118. N. Tokumoto, S. Ikeda, Y. Ishizaki, T. Kurihara, S. Ozaki, and M. Iseki Immunohistochemical and mutational analyses of Wnt signalling components and target genes in intrahepatic cholangiocarcinomas Int J Oncol 27 2005 973 980
119. J.S. Ross, K. Wang, L. Gay, R. Al-Rohil, J.V. Rand, and D.M. Jones New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing Oncologist 19 2014 235 242
120. Y.M. Wu, F. Su, S. Kalyana-Sundaram, N. Khazanov, B. Ateeq, and X. Cao Identification of targetable FGFR gene fusions in diverse cancers Cancer Discov 3 2013 636 647
121. Y. Arai, Y. Totoki, F. Hosoda, T. Shirota, N. Hama, and H. Nakamura Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma Hepatology 59 2014 1427 1434
122. M.J. Borad, M.D. Champion, J.B. Egan, W.S. Liang, R. Fonseca, and A.H. Bryce Integrated genomic characterization reveals novel, therapeutically relevant drug targets in FGFR and EGFR pathways in sporadic intrahepatic cholangiocarcinoma PLoS Genet 10 2014 e1004135
123. S.K. Saha, C.A. Parachoniak, K.S. Ghanta, J. Fitamant, K.N. Ross, and M.S. Najem Mutant IDH inhibits HNF-4alpha to block hepatocyte differentiation and promote biliary cancer Nature 513 2014 110 114